Bright Minds Biosciences Inc. · CSE:DRUG
Perceptive Advisors LLC's stake in Bright Minds Biosciences Inc. fell to 4.60% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Perceptive Advisors LLC's stake in Bright Minds Biosciences Inc. fell to 4.60%, 449,290 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.60%
- Shares
- 449,290
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 4.60% | 449,290 |
| Joseph Edelman | 4.60% | 449,290 |
| Perceptive Life Sciences Master Fund, Ltd. | 4.60% | 449,290 |
Source
Related
- Bright Minds Biosciences Inc.
- Perceptive Advisors LLC
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026